The Net Margin of Lineage Cell Therapeutics Inc (LCTX) is -195.90%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2024-12-31 | -195.90% |
| 2023-12-31 | -240.20% |
| 2022-12-31 | -178.71% |
| 2021-12-31 | -991.24% |
| 2020-12-31 | -1128.42% |
| 2019-12-31 | -332.67% |
| 2018-12-31 | -921.64% |
| 2017-12-31 | -577.46% |
| 2016-12-31 | 567.06% |
| 2015-12-31 | -667.47% |